KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Change in Cash (2016 - 2025)

Cvs Health (CVS) has disclosed Change in Cash for 17 consecutive years, with -$640.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 136.7% year-over-year to -$640.0 million, compared with a TTM value of -$172.0 million through Dec 2025, down 147.91%, and an annual FY2025 reading of -$172.0 million, down 147.91% over the prior year.
  • Change in Cash was -$640.0 million for Q4 2025 at Cvs Health, up from -$2.7 billion in the prior quarter.
  • Across five years, Change in Cash topped out at $5.1 billion in Q3 2022 and bottomed at -$5.7 billion in Q3 2024.
  • Average Change in Cash over 5 years is -$116.6 million, with a median of $251.5 million recorded in 2021.
  • The sharpest move saw Change in Cash tumbled 1120.06% in 2022, then skyrocketed 427.66% in 2024.
  • Year by year, Change in Cash stood at -$349.0 million in 2021, then crashed by 1120.06% to -$4.3 billion in 2022, then dropped by 13.9% to -$4.9 billion in 2023, then surged by 135.96% to $1.7 billion in 2024, then plummeted by 136.7% to -$640.0 million in 2025.
  • Business Quant data shows Change in Cash for CVS at -$640.0 million in Q4 2025, -$2.7 billion in Q3 2025, and $1.7 billion in Q2 2025.